Scholarlink

<p>The necessity of prophylactic splenectomy for 4 gastric cancer with greater curvature invasion remains unclear, as this subtype was excluded from the pivotal JCOG0110 trial. This study aimed to evaluate the short-term and long-term outcomes of splenectomy specifically in this population. We analyzed patients with clinically diagnosed advanced (cT2 or deeper) type 4 gastric cancer invading the greater curvature who underwent radical total gastrectomy at 11 institutes between 2005 and 2015. To minimize selection bias, inverse probability of treatment weighting (IPTW) was performed. Patients with clinical No. 10 lymph node metastasis or direct splenic invasion were excluded. A total of 95 patients were included (Splenectomy: <i>n</i> = 48; NonSplenectomy: <i>n</i> = 47) after IPTW adjustment. The Splenectomy group had a significantly higher incidence of intra-abdominal infectious complications compared to the NonSplenectomy group (20.8% vs. 4.3%; <i>p</i> = 0.04). Pathological metastasis to the No. 10 nodes was confirmed in 22.9% of the Splenectomy group. However, no significant differences were observed between the two groups in either 5-year relapse-free survival (HR 0.99; <i>p</i> = 0.66) or 5-year overall survival (HR 1.22; <i>p</i> = 0.91). Peritoneal dissemination was the predominant pattern of recurrence in both groups (&gt; 94%). For type 4 gastric cancer invading the greater curvature, prophylactic splenectomy increases the risk of postoperative infectious complications without providing a survival advantage.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Lack of oncological significance of prophylactic splenectomy for type 4 gastric cancer invading the greater curvature: a multicenter retrospective study

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月14日

查看全文
  • Masazumi Sakaguchi,
  • Yusuke Fujita,
  • Hisahiro Hosogi,
  • Michihiro Yamamoto,
  • Yosuke Kinjo,
  • Kosuke Toda,
  • Hiroaki Hata,
  • Masato Kondo,
  • Sanae Nakajima,
  • Tatsuto Nishigori,
  • Norihiro Shimoike,
  • Dai Manaka,
  • Atsushi Itami,
  • Yusuke Fujii,
  • Shoichi Kitano,
  • Atsushi Fukugaki,
  • Yoshiyuki Kiyasu,
  • Shintaro Okumura,
  • Kenjiro Hirai,
  • Shigeo Hisamori,
  • Shigeru Tsunoda,
  • Seiichiro Kanaya,
  • Kazutaka Obama

摘要

The necessity of prophylactic splenectomy for 4 gastric cancer with greater curvature invasion remains unclear, as this subtype was excluded from the pivotal JCOG0110 trial. This study aimed to evaluate the short-term and long-term outcomes of splenectomy specifically in this population. We analyzed patients with clinically diagnosed advanced (cT2 or deeper) type 4 gastric cancer invading the greater curvature who underwent radical total gastrectomy at 11 institutes between 2005 and 2015. To minimize selection bias, inverse probability of treatment weighting (IPTW) was performed. Patients with clinical No. 10 lymph node metastasis or direct splenic invasion were excluded. A total of 95 patients were included (Splenectomy: n = 48; NonSplenectomy: n = 47) after IPTW adjustment. The Splenectomy group had a significantly higher incidence of intra-abdominal infectious complications compared to the NonSplenectomy group (20.8% vs. 4.3%; p = 0.04). Pathological metastasis to the No. 10 nodes was confirmed in 22.9% of the Splenectomy group. However, no significant differences were observed between the two groups in either 5-year relapse-free survival (HR 0.99; p = 0.66) or 5-year overall survival (HR 1.22; p = 0.91). Peritoneal dissemination was the predominant pattern of recurrence in both groups (> 94%). For type 4 gastric cancer invading the greater curvature, prophylactic splenectomy increases the risk of postoperative infectious complications without providing a survival advantage.